Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase
Brittny C. Davis,Ian F. Thorpe +1 more
Reads0
Chats0
TLDR
Evidence that allosteric inhibition of NS5B results from intrinsic features of the enzyme free energy landscape, suggesting a common mechanism for the action of diverse allosterics ligands is presented.Abstract:
Hepatitis C virus (HCV) has infected almost 200 million people worldwide, typically causing chronic liver damage and severe complications such as liver failure. Currently, there are few approved treatments for viral infection. Thus, the HCV RNA-dependent RNA polymerase (gene product NS5B) has emerged as an important target for small molecule therapeutics. Potential therapeutic agents include allosteric inhibitors that bind distal to the enzyme active site. While their mechanism of action is not conclusively known, it has been suggested that certain inhibitors prevent a conformational change in NS5B that is crucial for RNA replication. To gain insight into the molecular origin of long-range allosteric inhibition of NS5B, we employed molecular dynamics simulations of the enzyme with and without an inhibitor bound to the thumb domain. These studies indicate that the presence of an inhibitor in the thumb domain alters both the structure and internal motions of NS5B. Principal components analysis identified motions that are severely attenuated by inhibitor binding. These motions may have functional relevance by facilitating interactions between NS5B and RNA template or nascent RNA duplex, with presence of the ligand leading to enzyme conformations with narrower and thus less accessible RNA binding channels. This study provides the first evidence for a mechanistic basis of allosteric inhibition in NS5B. Moreover, we present evidence that allosteric inhibition of NS5B results from intrinsic features of the enzyme free energy landscape, suggesting a common mechanism for the action of diverse allosteric ligands.read more
Citations
More filters
Posted Content
Selected-fit versus induced-fit protein binding: Kinetic differences and mutational analysis
TL;DR: In this paper, the authors consider the binding kinetics in a simple four-state model of ligand-protein binding and find a simple, characteristic difference between the on- and off-rates in the two mechanisms if the conformational relaxation into the ground states is fast.
Journal ArticleDOI
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase.
Robert G. Gentles,Min Ding,Bender John A,Bergstrom Carl P,Katharine A. Grant-Young,Piyasena Hewawasam,Thomas W. Hudyma,Scott W. Martin,Andrew Nickel,Alicia Regueiro-Ren,Yong Tu,Zhong Yang,Kap-Sun Yeung,Xiaofan Zheng,Sam T. Chao,Jung-Hui Sun,Brett R. Beno,Daniel M. Camac,Chong-Hwan Chang,Mian Gao,Paul E. Morin,Steven Sheriff,Jeff Tredup,John Wan,Mark R. Witmer,Dianlin Xie,Umesh Hanumegowda,Jay O. Knipe,Kathy Mosure,Kenneth S. Santone,Dawn D. Parker,Xiaoliang Zhuo,Julie A. Lemm,Mengping Liu,Lenore A. Pelosi,Karen Rigat,Voss Stacey A,Yi Wang,Ying-Kai Wang,Richard J. Colonno,Min Gao,Susan B. Roberts,Qi Gao,Alicia Ng,Nicholas A. Meanwell,John F. Kadow +45 more
TL;DR: Structural-activity relationship studies resulted in the optimization of the activity of members of a class of cyclopropyl-fused indolobenzazepine HCV NS5B polymerase inhibitors, and analogues exhibiting improved solubility and membrane permeability were shown to have notably enhanced pharmacokinetic profiles.
Journal ArticleDOI
Using the Hepatitis C Virus RNA-Dependent RNA Polymerase as a Model to Understand Viral Polymerase Structure, Function and Dynamics
Ester Sesmero,Ian F. Thorpe +1 more
TL;DR: The structural and functional properties of the HCV RNA-dependent RNA polymerase (NS5B) are reviewed in order to understand the fundamental processes underlying the replication of viral genomes.
Journal ArticleDOI
Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor.
Delia Tarantino,Rolando Cannalire,Eloise Mastrangelo,Romina Croci,Gilles Querat,Maria Letizia Barreca,Martino Bolognesi,Giuseppe Manfroni,Violetta Cecchetti,Mario Milani +9 more
TL;DR: A pyridobenzothiazole compound, HeE1-2Tyr, able to inhibit West Nile and Dengue RdRps activity in vitro, which proved effective against different flaviviruses in cell culture.
Journal ArticleDOI
Targets for antiviral therapy of hepatitis C.
Daniel Rupp,Ralf Bartenschlager +1 more
TL;DR: The authors briefly summarize the main features of viral and cellular factors involved in HCV replication that are utilized as therapy targets for chronic hepatitis C.
References
More filters
Journal ArticleDOI
Comparison of simple potential functions for simulating liquid water
TL;DR: In this article, the authors compared the Bernal Fowler (BF), SPC, ST2, TIPS2, TIP3P, and TIP4P potential functions for liquid water in the NPT ensemble at 25°C and 1 atm.
Journal ArticleDOI
CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
Bernard R. Brooks,Robert E. Bruccoleri,Barry D. Olafson,David J. States,S. Swaminathan,Martin Karplus +5 more
TL;DR: The CHARMM (Chemistry at Harvard Macromolecular Mechanics) as discussed by the authors is a computer program that uses empirical energy functions to model macromolescular systems, and it can read or model build structures, energy minimize them by first- or second-derivative techniques, perform a normal mode or molecular dynamics simulation, and analyze the structural, equilibrium, and dynamic properties determined in these calculations.
Journal ArticleDOI
Scalable molecular dynamics with NAMD
James C. Phillips,Rosemary Braun,Wei Wang,James C. Gumbart,Emad Tajkhorshid,Elizabeth Villa,Christophe Chipot,Robert D. Skeel,Laxmikant V. Kale,Klaus Schulten +9 more
TL;DR: NAMD as discussed by the authors is a parallel molecular dynamics code designed for high-performance simulation of large biomolecular systems that scales to hundreds of processors on high-end parallel platforms, as well as tens of processors in low-cost commodity clusters, and also runs on individual desktop and laptop computers.
Journal ArticleDOI
CHARMM: the biomolecular simulation program.
Bernard R. Brooks,Charles L. Brooks,Alexander D. MacKerell,Lennart Nilsson,Robert J. Petrella,Benoît Roux,Youngdo Won,Georgios Archontis,Christian Bartels,Stefan Boresch,Amedeo Caflisch,Leo S. D. Caves,Qiang Cui,Aaron R. Dinner,Michael Feig,Stefan Fischer,Jiali Gao,Milan Hodošček,Wonpil Im,K. Kuczera,Themis Lazaridis,Jianpeng Ma,V. Ovchinnikov,Emanuele Paci,Richard W. Pastor,Carol Beth Post,Jingzhi Pu,M. Schaefer,Bruce Tidor,Richard M. Venable,H. L. Woodcock,Xiongwu Wu,Wei Yang,Darrin M. York,Martin Karplus,Martin Karplus +35 more
TL;DR: An overview of the CHARMM program as it exists today is provided with an emphasis on developments since the publication of the original CHARMM article in 1983.